[HTML][HTML] The clinical–molecular interface of somatostatin, dopamine and their receptors in pituitary pathophysiology
The role of somatostatin and dopamine receptors as molecular targets for the treatment of
patients with pituitary adenomas is well established. Indeed, dopamine and somatostatin …
patients with pituitary adenomas is well established. Indeed, dopamine and somatostatin …
The clinical-molecular interface of somatostatin, dopamine and their receptors in pituitary pathophysiology
D Ferone, F Gatto, M Arvigo… - Journal of …, 2009 - pubmed.ncbi.nlm.nih.gov
The role of somatostatin and dopamine receptors as molecular targets for the treatment of
patients with pituitary adenomas is well established. Indeed, dopamine and somatostatin …
patients with pituitary adenomas is well established. Indeed, dopamine and somatostatin …
The clinical–molecular interface of somatostatin, dopamine and their receptors in pituitary pathophysiology
D Ferone, F Gatto, M Arvigo, E Resmini… - Journal of Molecular …, 2009 - cir.nii.ac.jp
抄録< jats: p> The role of somatostatin and dopamine receptors as molecular targets for the
treatment of patients with pituitary adenomas is well established. Indeed, dopamine and …
treatment of patients with pituitary adenomas is well established. Indeed, dopamine and …
The clinical-molecular interface of somatostatin, dopamine and their receptors in pituitary pathophysiology.
D Ferone, F Gatto, M Arvigo, E Resmini… - Journal of Molecular …, 2009 - europepmc.org
The role of somatostatin and dopamine receptors as molecular targets for the treatment of
patients with pituitary adenomas is well established. Indeed, dopamine and somatostatin …
patients with pituitary adenomas is well established. Indeed, dopamine and somatostatin …